Condition
Renal Insufficiency
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 54 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
54 shownFood Frequency Questionnaire to Assess Sodium IntakeNCT05533645 · 2023-06-06
RECRUITINGTolerability and Safety of CARDIOMEMS™ Intracardiac Continuous Cardiac Hemodynamic Monitoring Device in Patients with Cardio Renal Syndrome with Severe Renal ImpairmentNCT05428631 · 2022-08-26
RECRUITINGA Study of the Effect of a Nurse Navigator Program on High Risk PatientsNCT05592847 · 2027-01-01
NOT_YET_RECRUITINGChronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third WaveNCT06890208 · 2025-06-11
COMPLETEDChronical Illness-related Limitations of the Ability to Cope with Rising Temperatures: an Observational Study, 2nd WaveNCT06407154 · 2024-05-21
COMPLETEDChronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational StudyNCT05961163 · 2023-07-24
TERMINATEDExternal Validation of the VExUS Score for the Prediction of Acute Renal Failure in Cardiac SurgeryNCT05640518 · 2022-12-19
UNKNOWNPErirenal Adipose Tissue and RenaL Hemodynamics in Patients With Heart Failure With Preserved Ejection FractionNCT05219188 · 2022-02-01
UNKNOWNSpironolactone in CKD Enabled by Chlorthalidone: PILOTNCT05222191 · 2022-02-01
UNKNOWNHOLT-ED: Holter-monitoring in End-stage Renal DiseaseNCT04876963 · 2021-09-01
COMPLETEDChanges in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir DisproxilNCT04903847 · 2021-02-02
UNKNOWNTelmisartan Versus Enalapril in Heart Failure With Reduced Ejection Fraction Patients With Moderately Impaired Kidney FunctionsNCT04736329 · 2021-02-01
COMPLETEDSafety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical ConditionsNCT03899298 · 2019-09-01
NOT_YET_RECRUITINGEffects of SGLT2 Inhibitors on Erythropoiesis in Heart FailureNCT07478575 · 2019-01-01
ACTIVE_NOT_RECRUITINGCollection of Whole Blood Samples for the Evaluation of Preeclampsia (Pre-E) Biomarkers From Pregnant WomenNCT03767803 · 2018-10-01
UNKNOWNA Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems and Also to Check That MEDI0382 is Well ToleratedNCT03550378 · 2018-06-29
COMPLETEDHeart and Renal Failure in Hip Fracture SurgeryNCT03532919 · 2018-02-01
COMPLETEDSafety and Efficacy of High Protein Diet Versus GFR Based Protein Diet in Heart Failure Patients With Renal InsufficiencyNCT03213821 · 2017-11-01
UNKNOWNEffect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal InsufficiencyNCT03667300 · 2017-03-16
COMPLETEDInfluence of a Multi-parametric Optimization Strategy for General Anesthesia on Postoperative Morbidity and MortalityNCT02668250 · 2017-02-03
COMPLETEDEmpagliflozin in Renal Transplant RecipientsNCT03157414 · 2016-11-07
COMPLETEDCollection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) BiomarkersNCT02780414 · 2016-01-01
COMPLETEDSafety Study of Cenderitide in Chronic Stable Heart Failure With Moderate Renal ImpairmentNCT02603614 · 2015-12-01
COMPLETEDNovel Biomarkers for Risk Prediction of Contrast-Induced Acute Kidney Injury Post Coronary AngiographyNCT02263820 · 2015-01-01
COMPLETEDPilot Study for the Evaluation of the Safety and Performance of the RenaSense System in Hospitalized Acute Decompensated Heart Failure PatientsNCT02324400 · 2015-01-01
UNKNOWNClinical Trial in Patients With Hypertension and Left Ventricular DysfunctionNCT02148991 · 2014-07-01
COMPLETEDEffects of Chimeric Natriuretic Peptide Versus Placebo in Stable Heart Failure and Moderate Renal DysfunctionNCT01407900 · 2014-01-01
WITHDRAWNEfficacy and Safety of Alprostadil Prevent Contrast Induced NephropathyNCT01722513 · 2012-11-01
UNKNOWNPilot Study: Cardiovascular Events in High Risk Orthopedic Surgical PatientsNCT01809730 · 2012-05-01
WITHDRAWNBiomarkers Correlation With VolemiaNCT01858675 · 2012-03-01
COMPLETEDPharmacodynamic Comparison of Truncal Blocks in Patients With or Without Metabolic Disease (Kidney Failure, Diabetes)NCT01323075 · 2011-05-01
COMPLETEDIndapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal InsufficiencyNCT01172431 · 2010-09-01
COMPLETEDEfficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal ImpairmentNCT01164501 · 2010-07-01
COMPLETEDAn Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal ImpairmentNCT01064414 · 2010-06-01
COMPLETEDStudy of an Intervention to Improve Problem List Accuracy and UseNCT01105923 · 2010-05-01
UNKNOWNSafety and Efficacy of Low Dose Hypertonic Saline Solution and High Dose Furosemide for Congestive Heart FailureNCT01028170 · 2009-11-01
COMPLETEDRisk Factors of the Revisit of the Adult Heart Failure Patients in Emergency Department Siriraj HospitalNCT01373775 · 2009-04-01
COMPLETEDOral Tonapofylline (BG9928) in Patients With Heart Failure and Renal InsufficiencyNCT00745316 · 2009-02-01
TERMINATEDGlargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal InsufficiencyNCT00911625 · 2009-01-21
COMPLETEDSafety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)NCT00765830 · 2008-09-01
COMPLETEDSafety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)NCT00770081 · 2008-09-01
COMPLETEDStudy to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal InsufficiencyNCT00709865 · 2008-07-31
COMPLETEDConcentrated Saline Infusions and Increased Dietary Sodium With Diuretics for Heart Failure With Kidney DysfunctionNCT00575484 · 2007-11-01
TERMINATEDRenal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart FailureNCT00527059 · 2007-10-01
UNKNOWNA Comparison Of Study Drug Blood Levels After One Dose Of GSK189075 In Subjects With Normal And Reduced Kidney FunctionNCT00501462 · 2007-07-01
COMPLETEDExamining New Diagnostic Tests for Acute Kidney Injury After Heart SurgeryNCT00774137 · 2007-04-01
COMPLETEDNatrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMACNCT00338455 · 2006-09-01
TERMINATEDHaemoDYNAMICs in Primary and Secondary HypertensionNCT01742702 · 2006-05-25
UNKNOWNEffect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal ImpairmentNCT00159614 · 2005-09-01
COMPLETEDRenal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed TomographyNCT00209417 · 2005-06-01
TERMINATEDBNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS)NCT00186329 · 2004-03-01
COMPLETEDNesiritide Infusion for the Treatment of Decompensated Heart Failure and Renal DysfunctionNCT00119691 · 2003-04-01
COMPLETEDA Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)NCT00418366 · 2003-01-01
COMPLETEDEuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIVNCT02699736 · 1994-01-01
ENROLLING_BY_INVITATIONCommon interventions
PlaceboDRUG8TonapofyllineDRUG2vildagliptinDRUG20.25 units/kg daily insulinDRUG10.5 units/kg daily insulinDRUG13.7 mS, CT radiationRADIATION15% Dextrose in WaterDRUG1Alprostadil ﹠controlDRUG1Amniotic and Umbilical Cord Tissue ProcedureBIOLOGICAL1BI 10773DRUG1Biomarkers, red blood cells and plasma assessmentOTHER1Bisoprolol (5 mg daily for 3 weeks, recordings completed 2011)DRUG1CanagliflozinDRUG1CD-NPDRUG1CenderitideDRUG1ChlorthalidoneDRUG1Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO]DRUG1Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate 100 MG-300 MG-300 MG Oral Tablet [DELSTRIGO]DRUG1EmpagliflozinDRUG1EvogliptinDRUG1furosemideDRUG1furosemide and hypertonic saline solutionDRUG1GSK189075DRUG1Holter-monitorDEVICE1HydrochlorothiazideDRUG1
Leading sponsors
Universitätsklinikum Hamburg-Eppendorf
3
Biogen
2
Brigham and Women's Hospital
2
Centre Hospitalier Universitaire de Nīmes
2
Copenhagen University Hospital, Rigshospitalet
2
Novartis
2
Progenity, Inc.
2
Aspirus Heart and Vascular Institute-Research and Education
1
Barnes-Jewish Hospital
1
Boehringer Ingelheim
1
Cairo University
1
Capricor Inc.
1
Centre Hospitalier Universitaire de Saint Etienne
1
Elpen Pharmaceutical Co. Inc.
1
GE Healthcare
1
Trial status mix
COMPLETED30
UNKNOWN11
TERMINATED5
NOT_YET_RECRUITING2
RECRUITING2
WITHDRAWN2
ACTIVE_NOT_RECRUITING1
ENROLLING_BY_INVITATION1
Phase mix
PHASE210
NA8
PHASE48
PHASE16
PHASE36
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.